|
|
|
Volumn 9, Issue 5, 1997, Pages 213-215
|
|
NCI's anticancer drug screening program may not be selecting for clinically active compounds.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR PROTEIN;
ANIMAL;
CELL CULTURE;
CELL SURVIVAL;
CHEMISTRY;
DRUG EFFECT;
DRUG SCREENING;
HEALTH CARE ORGANIZATION;
HUMAN;
REVIEW;
STANDARD;
UNITED STATES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL SURVIVAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASM PROTEINS;
TUMOR CELLS, CULTURED;
UNITED STATES;
|
|
EID: 0030630924
PISSN: 09650407
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (49)
|
|
References (26)
|
